Khosla Impact

Khosla Impact, established in 2013, is an impact investment firm based in Menlo Park, California. It focuses on assisting high-impact entrepreneurs who develop products and services for the three billion people at the bottom of the world's economic pyramid. The firm invests in for-profit enterprises serving low-income individuals and small businesses in emerging markets, with a primary focus on South Asia. Khosla Impact encourages experimentation and supports entrepreneurs passionate about solving socio-economic challenges through technology and innovative business models.

Alex Bentley

Partner and Investor

Ryno Blignaut

Operating Partner

Alice Brooks

Principal

Peter Buckland

General Partner and COO

Brian Byun

Venture Partner

Catherine Casuga

Operating Partner

Bryan Gartner

Partner

Kanu Gulati

Partner

Judy Huang

Operating Partner

Jun Jeon

Principal

Samir Kaul

Founding Partner and Managing Director

Vinod Khosla

Managing Director

Kelly Kinnard

Operating Partner

Evan Moore

Partner

Alexander Morgan

Partner

Nicholas Moryl

Associate

Keith Rabois

Managing Director

Arash Rebek

Partner, Capital Formation

Jessy Rivest

Partner and Investor

Jai Sajnani

Partner

Jai Sajnani

Partner and Investor

Leah Scanlan

Operating Partner

Nikita Shamgunov

Partner

Sven Strohband

Managing Director

Rajesh Swaminathan

Partner

David Weiden

Managing Director

Reze Wong

Partner

Adam Coates

Operating Partner

Kanupriya Gulati Ph.D

Partner and Investor

Past deals in Personal Health

Aktiia

Series B in 2025
Aktiia focuses on continuous and accurate blood pressure monitoring to address the global challenge of hypertension, which affects over 1.4 billion people and contributes to more than 18 million deaths annually. Founded on two decades of research, Aktiia's innovative technology combines optical sensors with clinically validated software algorithms to provide personalized, medical-grade blood pressure and heart rate data. This continuous monitoring enables individuals, researchers, and clinicians to gain deeper insights into hypertension, fostering more effective and personalized patient care. By improving accessibility and accuracy in blood pressure management, Aktiia aims to change the approach to this critical health issue, ultimately enhancing the understanding and treatment of high blood pressure.

HealthifyMe

Series D in 2024
HealthifyMe is a fitness application designed to help users achieve their health and weight loss objectives through their computers and smartphones. Launched in 2012 by a team of doctors, nutritionists, and fitness trainers in Bangalore, India, the app allows users to track their calorie intake, monitor nutrition and fitness activities, and assess their weight to determine overall health. With features that enable users to set and work towards healthy goals, the platform also facilitates data sharing with experts, who provide personalized advice and recommendations. The application is enhanced by an artificial intelligence-powered fitness coach that leverages automated analytics, making it easier for users to receive tailored online fitness consultations and achieve their health aspirations.

Viome Life Sciences

Series D in 2024
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.

Aktiia

Series A in 2024
Aktiia focuses on continuous and accurate blood pressure monitoring to address the global challenge of hypertension, which affects over 1.4 billion people and contributes to more than 18 million deaths annually. Founded on two decades of research, Aktiia's innovative technology combines optical sensors with clinically validated software algorithms to provide personalized, medical-grade blood pressure and heart rate data. This continuous monitoring enables individuals, researchers, and clinicians to gain deeper insights into hypertension, fostering more effective and personalized patient care. By improving accessibility and accuracy in blood pressure management, Aktiia aims to change the approach to this critical health issue, ultimately enhancing the understanding and treatment of high blood pressure.

Bold

Series A in 2023
Bold is an at-home digital fitness program designed to help older adults live their strongest, happiest, and healthiest lives. As a member, you’ll enjoy instant access to expert trainers, scientific assessments, and personalized workout plans to help you improve your strength, flexibility, and balance — so you can chase the life you want, at any age.

Viome Life Sciences

Series C in 2023
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.

SiPhox Health

Seed Round in 2023
SiPhox Health, based in Cambridge, Massachusetts, specializes in designing and manufacturing innovative diagnostic solutions. The company develops next-generation diagnostics infrastructure, including at-home test kits and central lab systems. Their flagship product is a disposable biosensor cartridge that assesses 17 blood biomarkers, providing insights into inflammation, hormonal health, metabolic fitness, and cardiovascular health. SiPhox Health's platform merges biochemistry, photonic chip technology, integrated photonics, electronics, and microfluidics to enable sensitive readouts of immunoassays and nucleic acid tests, facilitating point-of-need and at-home diagnostics.

SiPhox Health

Series A in 2023
SiPhox Health, based in Cambridge, Massachusetts, specializes in designing and manufacturing innovative diagnostic solutions. The company develops next-generation diagnostics infrastructure, including at-home test kits and central lab systems. Their flagship product is a disposable biosensor cartridge that assesses 17 blood biomarkers, providing insights into inflammation, hormonal health, metabolic fitness, and cardiovascular health. SiPhox Health's platform merges biochemistry, photonic chip technology, integrated photonics, electronics, and microfluidics to enable sensitive readouts of immunoassays and nucleic acid tests, facilitating point-of-need and at-home diagnostics.

HealthifyMe

Series D in 2023
HealthifyMe is a fitness application designed to help users achieve their health and weight loss objectives through their computers and smartphones. Launched in 2012 by a team of doctors, nutritionists, and fitness trainers in Bangalore, India, the app allows users to track their calorie intake, monitor nutrition and fitness activities, and assess their weight to determine overall health. With features that enable users to set and work towards healthy goals, the platform also facilitates data sharing with experts, who provide personalized advice and recommendations. The application is enhanced by an artificial intelligence-powered fitness coach that leverages automated analytics, making it easier for users to receive tailored online fitness consultations and achieve their health aspirations.

Viome Life Sciences

Series C in 2022
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.

Good Health Company (Clinic) (GHC)

Series A in 2022
Mars is a men's wellness brand. The company provides hair, beard, skin, performance and wellness products. Mars was established on January 31, 2021 by Samarth Sindhi in Hyderabad, Andhra Pradesh.

Mirvie

Series B in 2022
Mirvie is a biotech company focused on developing non-invasive tests aimed at improving maternal-fetal health. Founded in 2018 and based in South San Francisco, California, Mirvie offers a medical diagnostic platform that provides actionable insights for mothers and families throughout their pregnancy journey. The company's innovative predictive tests help medical practitioners identify at-risk pregnancies, allowing for timely interventions and enhanced management of pregnancy-related concerns. By prioritizing safety and health, Mirvie seeks to empower families with the information necessary for better pregnancy outcomes.

Cor

Series A in 2022
COR helps you implement globally-proven healthy lifestyle practices, then shows you a totally new type of data about how your body responds. Optimize your lifestyle and discover the impact of different daily customs with precise, science-based self-knowledge.

Viome Life Sciences

Series C in 2021
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.

Because Market

Series B in 2021
Because Market is a direct-to-consumer personal care company established in 2017, specializing in products tailored for older adults. The company aims to simplify access to essential health and wellness items, including incontinence underwear, pads, skincare, supplements, and walkers. By providing discreet delivery and flexible subscription options, Because Market facilitates the purchasing process for families seeking to support their senior members. With aspirations to become the most trusted brand in this sector, the company has secured over $40 million in funding from prominent venture capital firms, reflecting its commitment to enhancing the lives of older adults and promoting their independence.

HealthifyMe

Series C in 2021
HealthifyMe is a fitness application designed to help users achieve their health and weight loss objectives through their computers and smartphones. Launched in 2012 by a team of doctors, nutritionists, and fitness trainers in Bangalore, India, the app allows users to track their calorie intake, monitor nutrition and fitness activities, and assess their weight to determine overall health. With features that enable users to set and work towards healthy goals, the platform also facilitates data sharing with experts, who provide personalized advice and recommendations. The application is enhanced by an artificial intelligence-powered fitness coach that leverages automated analytics, making it easier for users to receive tailored online fitness consultations and achieve their health aspirations.

Good Health Company (Clinic) (GHC)

Seed Round in 2021
Mars is a men's wellness brand. The company provides hair, beard, skin, performance and wellness products. Mars was established on January 31, 2021 by Samarth Sindhi in Hyderabad, Andhra Pradesh.

Bold

Seed Round in 2021
Bold is an at-home digital fitness program designed to help older adults live their strongest, happiest, and healthiest lives. As a member, you’ll enjoy instant access to expert trainers, scientific assessments, and personalized workout plans to help you improve your strength, flexibility, and balance — so you can chase the life you want, at any age.

Curai Health

Series B in 2020
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company leverages artificial intelligence to provide chat-based primary care services, aiming to make high-quality and affordable healthcare accessible to everyone, anytime. Curai Health's platform integrates clinicians with advanced AI and machine learning tools to create a learning healthcare system that enhances the efficiency and cost-effectiveness of medical care. By facilitating better communication between patients and healthcare professionals, the platform aids in accurate diagnosis and treatment. Curai Health offers its services directly to consumers and through partnerships with enterprises.

Invoy

Series A in 2020
Invoy is a company focused on providing personalized nutrition and wellness services through innovative monitoring medical devices. By utilizing science, data, and artificial intelligence, Invoy's technology captures real-time data on individual metabolism, allowing for tailored nutritional recommendations. The company aims to enhance individual health and weight loss goals by addressing the unique body chemistry of each person. With an emphasis on affordability, Invoy offers breath analyzers for medical applications, enabling users to effectively monitor their health and optimize their wellness journey.

SiPhox Health

Seed Round in 2020
SiPhox Health, based in Cambridge, Massachusetts, specializes in designing and manufacturing innovative diagnostic solutions. The company develops next-generation diagnostics infrastructure, including at-home test kits and central lab systems. Their flagship product is a disposable biosensor cartridge that assesses 17 blood biomarkers, providing insights into inflammation, hormonal health, metabolic fitness, and cardiovascular health. SiPhox Health's platform merges biochemistry, photonic chip technology, integrated photonics, electronics, and microfluidics to enable sensitive readouts of immunoassays and nucleic acid tests, facilitating point-of-need and at-home diagnostics.

Yes Health

Series A in 2020
Yes Health Inc. is a California-based company that specializes in mobile health solutions, focusing on diabetes prevention and management. Founded in 2015, it offers a comprehensive application that provides personalized nutrition and fitness advice, as well as support from health coaches. The program is designed to engage users actively, making it accessible and effective for individuals looking to adopt healthier lifestyles and prevent the onset of diabetes. Yes Health's team comprises physicians, health coaches, and engineers who work together to create a program that is both affordable and easy to follow. In addition to prevention, the application also aids individuals already diagnosed with diabetes in managing their symptoms effectively, with the overarching mission of promoting lasting health habits and reducing the impact of diabetes.

Ginger

Series C in 2019
Ginger is a telemental health provider delivering evidence-based behavioral health coaching, therapy, and psychiatry from a smartphone. Ginger's on-demand system brings together behavioral health coaches, therapists, and psychiatrists, who work as a team to deliver personalized care, right through your smartphone. The app provides members with access to the support they need within seconds, 24/7, 365 days a year. Millions of people have access to Ginger through leading employers, health plans, and its network of partners.

Neurotrack

Series C in 2019
Neurotrack Technologies, Inc., established in 2012 and headquartered in Redwood City, California, specializes in digital health solutions for early detection and ongoing monitoring of cognitive impairment, particularly Alzheimer's and other dementias. The company offers a computer-based cognitive test, validated clinically and guided by patients, which can be administered in clinics or at home, fitting various workflows. Neurotrack's proprietary technology has been recognized with 11 patents and is registered as an FDA Class II medical device. The company has published 27 peer-reviewed papers, demonstrating its commitment to scientific rigor and innovation in transforming dementia diagnosis and management.

Future

Series A in 2019
Future, established in 2017 and headquartered in San Francisco, specializes in personalized online fitness coaching. The company offers one-on-one digital training sessions tailored to clients' needs, whether they're at home, in the gym, or on-the-go. Future's team of coaches comprises experienced professionals who have trained athletes, celebrities, and working individuals alike.

Daye

Seed Round in 2019
Daye Ltd is a gynecological health company based in London, United Kingdom, founded in 2018. The company develops, manufactures, and markets female hygiene products under the Your Daye brand, specializing in innovative tampons designed to address period-related issues. Notably, Daye offers CBD-infused tampons that provide a natural alternative to traditional painkillers for managing menstrual cramps. In addition to its tampons, Daye is creating an at-home vaginal microbiome screening kit that allows women to test for infections and microbiome disruptions conveniently. This kit aims to empower women in monitoring their gynecological health, potentially reducing the risk of sexually transmitted infections, gynecological cancers, and complications related to fertility and IVF. Furthermore, Daye plans to launch a comprehensive digital platform focused on gynecological health, aiming to alleviate the challenges women face throughout their health journeys from menstruation to menopause.

Because Market

Venture Round in 2019
Because Market is a direct-to-consumer personal care company established in 2017, specializing in products tailored for older adults. The company aims to simplify access to essential health and wellness items, including incontinence underwear, pads, skincare, supplements, and walkers. By providing discreet delivery and flexible subscription options, Because Market facilitates the purchasing process for families seeking to support their senior members. With aspirations to become the most trusted brand in this sector, the company has secured over $40 million in funding from prominent venture capital firms, reflecting its commitment to enhancing the lives of older adults and promoting their independence.

Eva

Venture Round in 2018
Higia Technologies, founded in 2016 and based in Mexico City, develops EVA, a wearable device aimed at assessing breast cancer risk. This non-invasive device features tactile sensors that map the breast's surface and surrounding areas, enabling women to monitor changes in breast temperature, size, and weight. Equipped with biosensors, EVA continuously tracks relevant information, providing users with accessible tools for breast health management.

Viome Life Sciences

Series B in 2018
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.

Ten Percent Happier

Seed Round in 2018
Ten Percent Happier, Inc. is a Boston-based company that offers a meditation platform aimed at individuals who may be skeptical about traditional meditation practices. Founded in 2013, the company provides a mobile application that facilitates learning, practicing, and tracking meditation behaviors. The platform features expert-led courses, articles, and podcasts designed to foster meaningful changes in users' lives. Additionally, Ten Percent Happier publishes books that contain practical instructions for meditation, ensuring accessibility for a diverse audience. The company focuses on delivering a clear and straightforward approach to meditation, combining various multimedia resources to engage users effectively.

Curai Health

Series A in 2018
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company leverages artificial intelligence to provide chat-based primary care services, aiming to make high-quality and affordable healthcare accessible to everyone, anytime. Curai Health's platform integrates clinicians with advanced AI and machine learning tools to create a learning healthcare system that enhances the efficiency and cost-effectiveness of medical care. By facilitating better communication between patients and healthcare professionals, the platform aids in accurate diagnosis and treatment. Curai Health offers its services directly to consumers and through partnerships with enterprises.

Future

Seed Round in 2018
Future, established in 2017 and headquartered in San Francisco, specializes in personalized online fitness coaching. The company offers one-on-one digital training sessions tailored to clients' needs, whether they're at home, in the gym, or on-the-go. Future's team of coaches comprises experienced professionals who have trained athletes, celebrities, and working individuals alike.

Neurotrack

Series B in 2018
Neurotrack Technologies, Inc., established in 2012 and headquartered in Redwood City, California, specializes in digital health solutions for early detection and ongoing monitoring of cognitive impairment, particularly Alzheimer's and other dementias. The company offers a computer-based cognitive test, validated clinically and guided by patients, which can be administered in clinics or at home, fitting various workflows. Neurotrack's proprietary technology has been recognized with 11 patents and is registered as an FDA Class II medical device. The company has published 27 peer-reviewed papers, demonstrating its commitment to scientific rigor and innovation in transforming dementia diagnosis and management.

Mirvie

Series A in 2018
Mirvie is a biotech company focused on developing non-invasive tests aimed at improving maternal-fetal health. Founded in 2018 and based in South San Francisco, California, Mirvie offers a medical diagnostic platform that provides actionable insights for mothers and families throughout their pregnancy journey. The company's innovative predictive tests help medical practitioners identify at-risk pregnancies, allowing for timely interventions and enhanced management of pregnancy-related concerns. By prioritizing safety and health, Mirvie seeks to empower families with the information necessary for better pregnancy outcomes.

DiscernDx

Seed Round in 2018
DiscernDx is a healthcare technology company based in Palo Alto, California, founded in 2017. It operates an online platform that provides users with access to individualized clinical and molecular data, enabling proactive health management and informed decision-making. The platform leverages artificial intelligence and machine learning to detect, measure, and interpret signals from the body, facilitating early disease detection and personalized care. By focusing on the earliest indicators of developing diseases as well as existing conditions, DiscernDx aims to improve health outcomes and transform the healthcare experience for individuals.

Viome Life Sciences

Series A in 2017
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.

Vida Health

Series B in 2016
Vida Health, Inc. is a virtual care company based in San Francisco, California, focused on addressing chronic physical and behavioral health conditions. The company offers a comprehensive digital platform that combines artificial intelligence with human support, providing users access to coaches, nutritionists, diabetes educators, nurses, trainers, and licensed therapists. This platform features personalized content, lessons, and habit recommendations, along with video sessions and messaging to facilitate communication. Vida Health's approach aims to treat the whole health of individuals by integrating mental and physical care, helping users prevent, manage, and potentially reverse chronic conditions such as diabetes and hypertension, as well as associated mental health issues like stress, depression, and anxiety. Founded in 2014, Vida Health has earned the trust of major employers and health plans in the United States for its clinically validated services.

Luminostics

Convertible Note in 2016
Luminostics, Inc. is a healthcare technology company based in Houston, Texas, established in 2015. The company has developed a smartphone-based adaptor that enables users to conduct molecular-level health assessments through do-it-yourself disease testing. This innovative solution allows healthcare professionals and consumers to obtain health information quickly, with tests that can be completed in just 15 minutes. By combining mobile technology with accessible testing methods, Luminostics aims to enhance the way individuals monitor and manage their health.

AVA

Seed Round in 2016
AVA, Inc. is a Boston-based company that offers a messaging-based platform designed to enhance individuals' relationships with food and nutritional health. Established in 2016, AVA enables users to track their food choices, calculate meal calories, and receive personalized meal recommendations tailored to their dietary needs. The platform incorporates dedicated nutritional coaching to facilitate healthier eating habits. As of November 2019, AVA operates as a subsidiary of Koninklijke DSM N.V.

Neurotrack

Series A in 2016
Neurotrack Technologies, Inc., established in 2012 and headquartered in Redwood City, California, specializes in digital health solutions for early detection and ongoing monitoring of cognitive impairment, particularly Alzheimer's and other dementias. The company offers a computer-based cognitive test, validated clinically and guided by patients, which can be administered in clinics or at home, fitting various workflows. Neurotrack's proprietary technology has been recognized with 11 patents and is registered as an FDA Class II medical device. The company has published 27 peer-reviewed papers, demonstrating its commitment to scientific rigor and innovation in transforming dementia diagnosis and management.

Ginger

Series B in 2014
Ginger is a telemental health provider delivering evidence-based behavioral health coaching, therapy, and psychiatry from a smartphone. Ginger's on-demand system brings together behavioral health coaches, therapists, and psychiatrists, who work as a team to deliver personalized care, right through your smartphone. The app provides members with access to the support they need within seconds, 24/7, 365 days a year. Millions of people have access to Ginger through leading employers, health plans, and its network of partners.

Misfit Wearables

Series C in 2014
Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.

Vida Health

Series A in 2014
Vida Health, Inc. is a virtual care company based in San Francisco, California, focused on addressing chronic physical and behavioral health conditions. The company offers a comprehensive digital platform that combines artificial intelligence with human support, providing users access to coaches, nutritionists, diabetes educators, nurses, trainers, and licensed therapists. This platform features personalized content, lessons, and habit recommendations, along with video sessions and messaging to facilitate communication. Vida Health's approach aims to treat the whole health of individuals by integrating mental and physical care, helping users prevent, manage, and potentially reverse chronic conditions such as diabetes and hypertension, as well as associated mental health issues like stress, depression, and anxiety. Founded in 2014, Vida Health has earned the trust of major employers and health plans in the United States for its clinically validated services.

Misfit Wearables

Series B in 2013
Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.

Jawbone

Private Equity Round in 2013
Jawbone, established in 2006, is a pioneering company in the personal technology sector, renowned for its innovative and stylish products. Initially gaining traction with its award-winning Bluetooth headsets featuring industry-leading NoiseAssassin™ technology, which eliminates background noise for crystal-clear calls, the company has since expanded into the wearable technology market. Jawbone is now recognized for developing smart fitness tracking devices, such as the UP series, which monitor daily activity, sleep patterns, and eating habits, empowering users to make healthier lifestyle choices through its open API, the UP Platform.

Embrace Global

Series A in 2013
Embrace Global is a healthcare technology company based in Bengaluru, India, focused on developing affordable medical devices for emerging markets. The company is known for its flagship product, the Embrace Nest, a portable infant warmer designed to assist low birth-weight and premature babies. This innovative solution offers a cost-effective alternative to traditional incubators, priced at less than 1% of current options, thereby addressing the critical need to reduce mortality rates among the estimated 20 million premature-birth-weight infants who die each year. In addition to its existing products, Embrace Global engages in research and development to create new low-cost innovations aimed at improving maternal and child health.

Ginger

Series A in 2012
Ginger is a telemental health provider delivering evidence-based behavioral health coaching, therapy, and psychiatry from a smartphone. Ginger's on-demand system brings together behavioral health coaches, therapists, and psychiatrists, who work as a team to deliver personalized care, right through your smartphone. The app provides members with access to the support they need within seconds, 24/7, 365 days a year. Millions of people have access to Ginger through leading employers, health plans, and its network of partners.

Misfit Wearables

Series A in 2012
Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.

Jawbone

Series B in 2008
Jawbone, established in 2006, is a pioneering company in the personal technology sector, renowned for its innovative and stylish products. Initially gaining traction with its award-winning Bluetooth headsets featuring industry-leading NoiseAssassin™ technology, which eliminates background noise for crystal-clear calls, the company has since expanded into the wearable technology market. Jawbone is now recognized for developing smart fitness tracking devices, such as the UP series, which monitor daily activity, sleep patterns, and eating habits, empowering users to make healthier lifestyle choices through its open API, the UP Platform.

Jawbone

Series A in 2007
Jawbone, established in 2006, is a pioneering company in the personal technology sector, renowned for its innovative and stylish products. Initially gaining traction with its award-winning Bluetooth headsets featuring industry-leading NoiseAssassin™ technology, which eliminates background noise for crystal-clear calls, the company has since expanded into the wearable technology market. Jawbone is now recognized for developing smart fitness tracking devices, such as the UP series, which monitor daily activity, sleep patterns, and eating habits, empowering users to make healthier lifestyle choices through its open API, the UP Platform.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.